Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1295485

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1295485

Surgical Procedures Market by Type (Gastrointestinal, Cardiovascular, Dental, Cosmetic, Urologic, Ophthalmic, Orthopedic, ENT, Nervous System, Obstetric/Gynecologic), Channel (Physician Offices, Hospitals, ASCs) - US Forecast to 2028

PUBLISHED:
PAGES: 86 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

The US surgical procedures market is projected to reach 1,27,748.5 thousand procedures by 2028 from 1,08,275.5 thousand procedures in 2023, at a CAGR of 3.4% during the forecast period. Growth in the US surgical procedures market is mainly attributed to the rapidly ageing population leading to a higher demand for surgical interventions, the increasing prevalence of chronic diseases, and the advancements in surgical techniques propelled by technological innovations. Conversely, complications associated with surgical procedures, dearth of surgeons and surgical errors are expected to challenge market growth to a certain extent.

Ophthalmic surgical procedures segment is projected to grow at the highest CAGR during the forecast period

Based on type, the US surgical procedures market is segmented into dental, cosmetic, urologic, gastrointestinal, ENT, ophthalmic, obstetric/gynecologic, cardiovascular, orthopedic and other surgical procedures. In 2022, the dental surgical procedures segment accounted for the largest share of this market. The large share can be attributed to the increasing awareness of oral care, increasing prevalence of oral diseases, as well as rising ageing population and the associated teeth loss.

The ophthalmic surgical procedures segment is estimated to grow at the highest CAGR during the forecast period. According to the US CDC, ~12 million people 40 years and over in the US have vision impairment, including three million who have vision impairment after correction, one million who are blind, and eight million who have vision impairment due to uncorrected refractive error. The growth of the segment can be attributed to the prevalence of various ophthalmic disorders such as glaucoma, cataract, and diabetic retinopathy, especially among the geriatric population.

Ambulatory surgery centers segment is estimated to witness fastest growth during the forecast period

Based on channel, the US surgical procedures market is segmented into physician offices, hospitals, and ambulatory surgery centers. The hospitals segment is further bifurcated into inpatient and outpatient surgeries. In 2022, the physician offices segment accounted for the largest share of this market followed by hospitals and ambulatory surgery centers. The ambulatory surgery centers segment is estimated to grow at the highest CAGR during the forecast period. The preference for ASCs has risen due to numerous factors including lower costs than hospital outpatient departments (HOPDs), effective postoperative care, limited hospitalization time, limited risk of disease relapse, and faster patient recovery. A review of commercial medical claims published by the ASCA also reported that healthcare costs in the US were reduced by USD 38 billion each year due to the availability of ASCs as an alternative. The potential for cost reductions, the growing patient population, and the rising demand for better and quicker care among patients is expected to drive growth in ASCs.

Research Coverage

This report studies the US surgical procedures market based on type and channel. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. The report analyzes the US surgical procedures market and aims at estimating the surgical procedures volume and future growth potential of this market based on various segments and sub-segments.

Key Benefits of Buying the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Emerging Technology Analysis: Comprehensive information on the lucrative emerging technological advancements in surgical procedures
  • Quantitative Analysis: Exhaustive information about number of various types of surgeries performed in the US.
Product Code: MD 6867

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 US SURGICAL PROCEDURES MARKET
    • 1.3.2 YEARS CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 UNITS CONSIDERED
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH METHODOLOGY STEPS
    • FIGURE 2 RESEARCH METHODOLOGY: US SURGICAL PROCEDURES MARKET
    • FIGURE 3 RESEARCH DESIGN
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key secondary sources
    • 2.2.2 PRIMARY DATA
      • 2.2.2.1 Key insights from primary sources
  • 2.3 MARKET ESTIMATION
    • FIGURE 4 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, OPPORTUNITIES, AND CHALLENGES (2023-2028)
  • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 5 DATA TRIANGULATION METHODOLOGY
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT: US SURGICAL PROCEDURES MARKET
  • 2.7 LIMITATIONS
  • 2.8 IMPACT OF COVID-19 ON US SURGICAL PROCEDURES MARKET
  • 2.9 RECESSION IMPACT: US SURGICAL PROCEDURES MARKET
    • FIGURE 6 US HEALTHCARE INFLATION-PERCENT INCREASE

3 EXECUTIVE SUMMARY

    • FIGURE 7 US SURGICAL PROCEDURES MARKET, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES)
    • FIGURE 8 DENTAL SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES)
    • FIGURE 9 ORTHOPEDIC SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES)
    • FIGURE 10 GASTROINTESTINAL SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES)
    • FIGURE 11 OPHTHALMIC SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES)
    • FIGURE 12 CARDIOVASCULAR SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES)
    • FIGURE 13 OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES MARKET, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES)
    • FIGURE 14 COSMETIC SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES)
    • FIGURE 15 ENT SURGICAL PROCEDURES MARKET, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES)
    • FIGURE 16 UROLOGIC SURGICAL PROCEDURES, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES)
    • FIGURE 17 US SURGICAL PROCEDURES MARKET, BY CHANNEL, 2023 VS. 2028 (THOUSAND PROCEDURES)

4 PREMIUM INSIGHTS

  • 4.1 US SURGICAL PROCEDURES MARKET OVERVIEW
    • FIGURE 18 TECHNOLOGICAL ADVANCEMENTS IN SURGICAL PROCEDURES TO DRIVE MARKET GROWTH
  • 4.2 US SURGICAL PROCEDURES MARKET, BY TYPE & CHANNEL
    • FIGURE 19 DENTAL SURGICAL PROCEDURES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
  • 4.3 US SURGICAL PROCEDURES MARKET FOR HOSPITALS, BY TYPE
    • FIGURE 20 INPATIENT SURGERIES TO DOMINATE MARKET OVER FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 21 US SURGICAL PROCEDURES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing prevalence of cancer requiring surgical treatment
    • FIGURE 22 US: ESTIMATED NEW CASES AND DEATHS FOR EACH COMMON CANCER TYPE IN 2023
    • FIGURE 23 US: CANCER CASES, BY TYPE, 2020-2040 (THOUSANDS)
    • FIGURE 24 US: NEW CANCER CASES, 2012-2022 (MILLION INDIVIDUALS)
      • 5.2.1.2 Growth in geriatric population and rise in chronic disease prevalence
    • FIGURE 25 US: NUMBER OF PEOPLE WITH CHRONIC CONDITIONS, 1995-2030 (MILLION)
      • 5.2.1.3 Increasing rate of organ transplantation
    • TABLE 2 US: SINGLE-ORGAN TRANSPLANTS PERFORMED, 2016-2020
      • 5.2.1.4 Technological advancements in surgical procedures
    • FIGURE 26 US: R&D INVESTMENTS IN MEDICAL TECHNOLOGY, 2013-2018 (MILLION)
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 Increasing adoption of outpatient surgeries
      • 5.2.2.2 Improved surgical techniques in bariatric procedures
    • TABLE 3 BARIATRIC SURGERIES PERFORMED, 2016-2020
    • 5.2.3 CHALLENGES
      • 5.2.3.1 Surgical errors
      • 5.2.3.2 Complications associated with surgical procedures
    • TABLE 4 COMPLICATIONS ASSOCIATED WITH SURGICAL PROCEDURES
      • 5.2.3.3 Shortage of surgeons

6 INDUSTRY INSIGHTS

  • 6.1 INDUSTRY TRENDS
    • 6.1.1 MINIMALLY INVASIVE SURGERY
    • 6.1.2 INCREASING ADOPTION OF ADVANCED ROBOTICS IN ASCS
  • 6.2 PRICING ANALYSIS
    • TABLE 5 TYPICAL AVERAGE COSTS FOR SOME COMMON SURGERIES
  • 6.3 REIMBURSEMENT SCENARIO
    • TABLE 6 LIST OF SURGICAL PROCEDURE CODES
    • TABLE 7 COSMETIC SURGERY PROCEDURE CODES
  • 6.4 TECHNOLOGY ANALYSIS
  • 6.5 REGULATORY LANDSCAPE

7 US SURGICAL PROCEDURES MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 8 US SURGICAL PROCEDURES MARKET, BY TYPE, 2021-2028 (THOUSANDS)
  • 7.2 DENTAL SURGICAL PROCEDURES
    • 7.2.1 RISING PREVALENCE OF ORAL DISEASES AND GROWING AWARENESS OF DENTAL CARE TO DRIVE GROWTH
    • TABLE 9 US: DENTAL SURGICAL PROCEDURES, BY TYPE, 2021-2028 (THOUSANDS)
  • 7.3 ORTHOPEDIC SURGICAL PROCEDURES
    • 7.3.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED DEVICES TO INCREASE PROCEDURAL VOLUMES
    • TABLE 10 US: ORTHOPEDIC SURGICAL PROCEDURES, BY TYPE, 2021-2028 (THOUSANDS)
  • 7.4 GASTROINTESTINAL SURGICAL PROCEDURES
    • 7.4.1 INCREASING NUMBER OF GASTROINTESTINAL CANCER CASES TO BOOST MARKET
    • FIGURE 27 US: STOMACH CANCER INCIDENCE, 2020-2040 (THOUSANDS)
    • TABLE 11 US: GASTROINTESTINAL SURGICAL PROCEDURES, BY TYPE, 2021-2028 (THOUSANDS)
  • 7.5 OPHTHALMIC SURGICAL PROCEDURES
    • 7.5.1 RISING PREVALENCE OF GLAUCOMA, CATARACT, AND DIABETIC RETINOPATHY TO DRIVE DEMAND FOR OPHTHALMIC SURGERY
    • TABLE 12 US: OPHTHALMIC SURGICAL PROCEDURES, BY TYPE, 2021-2028 (THOUSANDS)
  • 7.6 CARDIOVASCULAR SURGICAL PROCEDURES
    • 7.6.1 RISING PREVALENCE OF HEART DISEASE TO BOOST DEMAND FOR SURGERY
    • TABLE 13 US: NUMBER OF CVD CASES, 2015-2035 (MILLION)
    • TABLE 14 US: CARDIOVASCULAR SURGICAL PROCEDURES, BY TYPE, 2021-2028 (THOUSANDS)
  • 7.7 OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES
    • 7.7.1 INCREASING INCIDENCE OF GYNECOLOGICAL DISEASES TO DRIVE MARKET GROWTH
    • TABLE 15 US: OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES, BY TYPE, 2021-2028 (THOUSANDS)
  • 7.8 COSMETIC SURGICAL PROCEDURES
    • 7.8.1 ADVENT OF MINIMALLY INVASIVE SURGICAL PROCEDURES TO PROPEL ADOPTION OF COSMETIC SURGERIES
    • TABLE 16 US: COSMETIC SURGICAL PROCEDURES, BY TYPE, 2021-2028 (THOUSANDS)
  • 7.9 ENT SURGICAL PROCEDURES
    • 7.9.1 RISING DISPOSABLE INCOME AND INCREASING AFFORDABILITY TO BOOST GROWTH OF ENT SURGICAL PROCEDURES
    • TABLE 17 US: ENT SURGICAL PROCEDURES, BY TYPE, 2021-2028 (THOUSANDS)
  • 7.10 UROLOGIC SURGICAL PROCEDURES
    • 7.10.1 INCREASING KIDNEY DISEASE INCIDENCE TO BOOST PROCEDURAL VOLUME
    • TABLE 18 US: UROLOGIC SURGICAL PROCEDURES, BY TYPE, 2021-2028 (THOUSANDS)
  • 7.11 OTHER SURGICAL PROCEDURES
    • TABLE 19 US: OTHER SURGICAL PROCEDURES, BY TYPE, 2021-2028 (THOUSANDS)
    • TABLE 20 US: NERVOUS SYSTEM SURGICAL PROCEDURES, BY TYPE, 2021-2028 (THOUSANDS)
    • TABLE 21 US: ENDOCRINE SYSTEM SURGICAL PROCEDURES, BY TYPE, 2021-2028 (THOUSANDS)

8 US SURGICAL PROCEDURES MARKET, BY CHANNEL

  • 8.1 INTRODUCTION
    • TABLE 22 US SURGICAL PROCEDURES MARKET, BY CHANNEL, 2021-2028 (THOUSANDS)
  • 8.2 PHYSICIAN OFFICES
    • 8.2.1 PHYSICIAN OFFICES TO DOMINATE END-USER MARKET DUE TO TECHNOLOGICAL ADVANCES AND GROWING FEASIBILITY
  • 8.3 HOSPITALS
    • TABLE 23 US: NUMBER OF REGISTERED HOSPITALS, BY NUMBER OF BEDS (2019)
    • TABLE 24 US SURGICAL PROCEDURES MARKET FOR HOSPITALS, BY TYPE, 2021-2028 (THOUSANDS)
    • 8.3.1 INPATIENT SURGERIES
      • 8.3.1.1 Increasing incidence of cardiovascular, neurological, and intestinal disorders to drive market growth
    • 8.3.2 OUTPATIENT SURGERIES
      • 8.3.2.1 Convenience and lower cost to boost demand for outpatient surgeries
  • 8.4 AMBULATORY SURGERY CENTERS
    • 8.4.1 LOWER COSTS AND SHORTER PATIENT STAYS TO PROPEL GROWTH

9 APPENDIX

  • 9.1 DISCUSSION GUIDE
  • 9.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 9.3 RELATED REPORTS
  • 9.4 AUTHOR DETAILS
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!